FDA Clearance Tracker · DEN180028
23andMe Personal Genome Service (PGS) Pharmacogenetic Reports
Last checked: Nov 20, 2026Latest source record: Oct 31, 2018 (this decision)Source: openFDAMethods & limitations
Decided
Oct 31, 2018
De Novo granted
Time to decision
148 days
Received Jun 5, 2018. Calendar days, including time FDA spent waiting on the applicant.
Pathway
De Novo
Direct
Device class
Class II
The decision
- FDA number
- DEN180028
- Device name
- 23andMe Personal Genome Service (PGS) Pharmacogenetic Reports
- Applicant
- 23AndMe, Inc.
- Applicant location
- Mountain View, CA
- Received
- Jun 5, 2018
- Decided
- Oct 31, 2018
- Decision
- De Novo granted
- Submission type
- Direct
Device type
- Device class
- Class II
- Regulation
- 21 CFR 862.3364
- Specialty
- Laboratory Medicine & Pathology
How new is this?
These are facts about FDA's records. They are not a judgment about the device.
- FDA granted this as a De Novo request, which means it created a new device type. There was no existing device to compare it to.
- It is not on FDA's public list of Breakthrough Devices with marketing authorization (list dated June 30, 2026). FDA does not publish which devices hold the designation before they are authorized, and the list is updated only a few times a year.
Source documents
- FDA database record for DEN180028
- Decision summary (PDF) · FDA posts these some weeks after the decision, so a recent one may not open yet.
Other decisions for 23AndMe, Inc.
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
K223597 · Decided Aug 31, 2023 · 272 days after receipt
Device type: Cancer Predisposition Risk Assessment System (QAZ) · Laboratory Medicine & Pathology
K221885 · Decided Oct 26, 2022 · 119 days after receipt
Device type: Direct-To-Consumer Access Pharmacogenetic Assessment System (QDJ) · Laboratory Medicine & Pathology
K211499 · Decided Jan 6, 2022 · 237 days after receipt
Device type: Cancer Predisposition Risk Assessment System (QAZ) · Laboratory Medicine & Pathology
4 more FDA decisions with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.